Report Scope:
This research report incorporates an in-depth analysis of the pharmaceutical drugs market and its competitive landscape through 2021. Major players, competitive intelligence, innovative technologies and company profiles are discussed in detail. The report also examines recent developments and product portfolios of major players, and it features market share analysis and rankings in the market. It includes a regulatory landscape analysis that focuses on recent regulations in regions such as the U.S., Europe and Japan.

Report Includes:

  • 71 data tables and 54 additional tables
  • A brief general overview of the global pharmaceutical drugs industry competitive landscape
  • Analyses of the global market trends, with historic market revenue for 2016 to 2021, estimates for 2022, market forecasts for 2022-2026, and projections of compound annual growth rates (CAGRs) through 2027
  • Assessment of major driving factors, opportunities and challenges in this innovation driven market, with emphasis on recent developments in the pharmaceutical industry
  • Highlights of the current and future market potential of pharmaceutical industry along with a detailed analysis of the competitive environment, regulatory scenario and clinical trails
  • Discussion of the industry value chain analysis providing a systematic study of key intermediaries involved, with emphasis on recent developments and region-specific macroeconomic factors on global pharmaceutical drugs marketplace
  • Market assessment of the COVID-19 impact on the global pharmaceutical drugs market, along with its implications on demand and supply, price impact and various government strategic decisions
  • Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
  • Descriptive company profiles of the leading pharma manufacturers, including Abbott, Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline PLC, Pfizer Inc., Sanofi Corp., Takeda Pharmaceutical Co. Ltd. and Zydus Cadila